380 related articles for article (PubMed ID: 34482368)
1. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
[TBL] [Abstract][Full Text] [Related]
2. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
Bonaccorso S; Sodhi M; Li J; Bobo WV; Chen Y; Tumuklu M; Theleritis C; Jayathilake K; Meltzer HY
Bipolar Disord; 2015 Aug; 17(5):528-35. PubMed ID: 25874530
[TBL] [Abstract][Full Text] [Related]
3. Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.
Tsai A; Liou YJ; Hong CJ; Wu CL; Tsai SJ; Bai YM
Neuromolecular Med; 2011 Dec; 13(4):328-33. PubMed ID: 21956459
[TBL] [Abstract][Full Text] [Related]
4. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
[TBL] [Abstract][Full Text] [Related]
5. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
[TBL] [Abstract][Full Text] [Related]
6. The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
Zai GC; Zai CC; Chowdhury NI; Tiwari AK; Souza RP; Lieberman JA; Meltzer HY; Potkin SG; Müller DJ; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):96-101. PubMed ID: 22642961
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study.
Liu H; Yu R; Gao Y; Li X; Guan X; Thomas K; Xiu M; Zhang X
Curr Neuropharmacol; 2022 Aug; 20(9):1774-1782. PubMed ID: 34544343
[TBL] [Abstract][Full Text] [Related]
8. Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls.
Fang H; Zhen YF; Liu XY; Xu G; Soares JC; Zhao J; Zhang XY
Int Clin Psychopharmacol; 2016 Nov; 31(6):353-7. PubMed ID: 27483421
[TBL] [Abstract][Full Text] [Related]
9. The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain.
Fonseka TM; Tiwari AK; Gonçalves VF; Lieberman JA; Meltzer HY; Goldstein BI; Kennedy JL; Kennedy SH; Müller DJ
World J Biol Psychiatry; 2015 Jan; 16(1):45-56. PubMed ID: 25560300
[TBL] [Abstract][Full Text] [Related]
10. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
11. Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.
Song X; Pang L; Feng Y; Fan X; Li X; Zhang W; Gao J; Zhang J; Nemani K; Zhang H; Lv L
Behav Brain Funct; 2014 Oct; 10(1):35. PubMed ID: 25278160
[TBL] [Abstract][Full Text] [Related]
12. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.
Chen YQ; Li XR; Zhang L; Zhu WB; Wu YQ; Guan XN; Xiu MH; Zhang XY
J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004092
[TBL] [Abstract][Full Text] [Related]
14. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
15. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
[TBL] [Abstract][Full Text] [Related]
16. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
[TBL] [Abstract][Full Text] [Related]
17. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
19. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
[TBL] [Abstract][Full Text] [Related]
20. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
